{
  "title": "Cancer Gene Therapy Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "cancer-gene-therapy-market",
  "industry": "Biotechnology & Genomics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/cancer-gene-therapy-market",
  "scraped_at": "2026-09-17T17:43:32+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 29.43,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 67.11,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 17.92,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "Medium"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "What is the current size of the cancer gene therapy market?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The cancer gene therapy market size reached USD 29.43 billion in 2026 and is projected to grow rapidly at an 17.92% CAGR to 2031."
      }
    },
    {
      "@type": "Question",
      "name": "Which therapy modality holds the largest market share?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Oncolytic virotherapy leads with 43.02% share, benefiting from established clinical use and regulatory familiarity."
      }
    },
    {
      "@type": "Question",
      "name": "Which region is expanding fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific is forecast to post a 29.82% CAGR through 2031, supported by China's manufacturing base and accelerated regulatory pathways."
      }
    },
    {
      "@type": "Question",
      "name": "How are high therapy prices being addressed?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Payers and manufacturers are piloting value-based contracts and installment payment models to spread costs and tie reimbursement to outcomes."
      }
    },
    {
      "@type": "Question",
      "name": "What technological trend is most disruptive?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "CRISPR-based editing platforms, especially when paired with lipid nanoparticle delivery, are reshaping pipelines for both hematologic and solid tumors."
      }
    }
  ],
  "images": [
    "images/cancer-gene-therapy-market-size-image-1775130977853.png",
    "images/cancer-gene-therapy-market-Cancer-Gene-Therapy-Market-Market-Share-by-Therapy-Modality-2025-1768460462054.png",
    "images/cancer-gene-therapy-market-Cancer-Gene-Therapy-Market-Market-Share-by-Cancer-Type-2025-1768460466394.png",
    "images/cancer-gene-therapy-market-Cancer-Gene-Therapy-Market-CAGR--Growth-Rate-by-Region-2026---2031-1768460470714.png",
    "images/cancer-gene-therapy-market-competitive-landscape-1752244227973.png",
    "images/market-snapshot.png",
    "images/pdf3.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/cancer-gene-therapy-market-size-image-1775130977853.png"
  ],
  "sections_count": 11
}